Analysis and management of cochlear implant explantation in adults - Réhabilitation Chirurgicale mini-Invasive et Robotisée de l'Audition Access content directly
Journal Articles European Annals of Otorhinolaryngology, Head and Neck Diseases Year : 2020

Analysis and management of cochlear implant explantation in adults

Abstract

Objectives: Cochlear implants have a 10-year manufacturer's warranty and may remain functional for more than 25 years after implantation. With the increasing number of users, the number of explantations is set to increase in the future. The main objective of the present study was to determine reasons for cochlear explantation in adults and the proportion carried out during the warranty period.Material and methods: A single-centre retrospective multidisciplinary study of cochlear explantation in adults was performed over a 33-month period. Explantation reasons, interval since implantation and warranty application were analysed.Results: 54% of the 71 explantations were for medical reasons, 45% due to failure (35% "hard failure", 10% "soft failure") and 1% could not be classified; 69% were followed by reimplantation. Failure was confirmed before explantation in 66% of cases. Manufacturer warranties were applicable in 70% of explantations for breakdown, for a total of €335,500.Conclusions: This analysis provides decision support for reimplantation and allows better patient information. Follow-up is essential to optimise warranty application and to promote the proper implant use.
Fichier principal
Vignette du fichier
S1879729620300910.pdf (780.92 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03492840 , version 1 (21-11-2022)

Licence

Identifiers

Cite

M. Bourdoncle, C. Fargeot, C. Poncet, I. Mosnier. Analysis and management of cochlear implant explantation in adults. European Annals of Otorhinolaryngology, Head and Neck Diseases, 2020, 137, pp.459 - 465. ⟨10.1016/j.anorl.2020.04.001⟩. ⟨hal-03492840⟩
1002 View
134 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More